Vericel Corp (VCEL)

↓ Download CSV

CIK 0000887359 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated MI
  • Fiscal year ends Dec 31

In fiscal 2025, Vericel Corp reported revenue of $276.26M, up 16.5% from the prior year. The company was profitable, with a net margin of 6.0% and a gross margin of 74.4%. It held $487.97M in total assets against $133.33M in total liabilities.

Key ratios (FY2025)

74.4%
Gross margin
4.0%
Operating margin
6.0%
Net margin
4.7%
Return on equity
+16.5%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$276.26M$237.22M$197.52M$163.70M$153.07M$121.97M$117.85M$90.86M$62.76M$54.38M
Cost of Revenue$70.66M$65.12M$61.94M$54.58M$50.16M$39.95M$37.57M$32.16M$30.35M$28.31M
Gross Profit$205.60M$172.11M$135.58M$109.79M$106.03M$84.23M$80.28M$58.70M$33.57M$26.08M
Operating Income$11.04M$4.52M-$6.46M-$17.06M-$7.85M$2.37M-$11.25M-$3.91M-$14.98M-$19.25M
Net Income$16.52M$10.36M-$3.18M-$16.71M-$7.47M$2.86M-$9.66M-$8.14M-$17.29M-$19.57M
EPS (Diluted)$0.32$0.20$-0.07$-0.35$-0.16$0.06$-0.22$-0.20
Total Assets$487.97M$432.72M$353.66M$273.00M$243.71M$205.61M$153.24M$118.69M$54.58M$48.60M
Total Liabilities$133.33M$140.75M$127.70M$80.73M$73.24M$71.35M$42.15M$16.46M$32.04M$23.89M
Shareholders' Equity$354.64M$291.97M$225.95M$192.27M$170.46M$134.26M$111.09M$102.23M$22.54M$24.71M
Cash & Equivalents$100.09M$74.52M$69.09M$51.07M$68.33M$33.62M$26.89M$18.29M
Operating Cash Flow$51.91M$58.16M$35.31M$17.69M$29.04M$17.57M-$7.18M-$412.0K-$13.18M-$19.89M
Capital Expenditures$27.16M$63.97M$20.01M$7.60M$7.92M$2.63M$2.62M$2.68M$1.51M$1.42M
Shares Outstanding50.62M49.63M47.83M47.25M46.88M45.80M44.86M43.58M35.86M31.59M